Avivagen Announces Two Year Distribution Agreement with PACC Pets and Attendance at Global Pet Expo
23. Februar 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that...
Avivagen to Seek Approval from TSX Venture Exchange for Extension of Warrants
13. Februar 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that...
Avivagen Announces Positive Results from Swine Trial
15. Januar 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a Corporation with a proven and commercially-ready, patent-protected product...
Avivagen Announces Positive Results from Dairy Cattle Trial
08. Januar 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product...
Avivagen Inc. Announces the Granting of Options
22. Dezember 2017 06:30 ET
|
Avivagen Inc.
OTTAWA, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that...
Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2017
20. Dezember 2017 06:30 ET
|
Avivagen Inc.
OTTAWA, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that...
Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants
08. Dezember 2017 10:51 ET
|
Avivagen Inc.
OTTAWA, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that...
Avivagen Announces Closing of Private Placement Totaling $4 million
30. November 2017 10:36 ET
|
Avivagen Inc.
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Nov. 30, 2017 ...
Avivagen Announces the Appointment of Mr. Aubrey Dan to the Board of Directors
22. November 2017 06:30 ET
|
Avivagen Inc.
OTTAWA, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a life sciences innovation company with a series of patent protected products that...
Cesar Millan helps Avivagen Relaunch Vivamune™ Health Chews in U.S.
23. Oktober 2017 08:00 ET
|
Avivagen Inc.
OTTAWA, Oct. 23, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (Avivagen) (TSX-V:VIV) (OTC Pink:CHEXF), a life sciences innovation company with a series of patent protected products that support and...